Remco van Doorn

8.9k citations

128 papers · 5.3k indexed · 1 hit paper · h-index 35

Co-authors: Rein Willemze Daniel S. Peeper Wolter J. Mooi Chrysiis Michaloglou Liesbeth C.W. Vredeveld Sirith Douma Christophe Desmet Lucien A. Aarden
Topics: Cutaneous Melanoma Detection and Management (26 papers)Cutaneous lymphoproliferative disorders research (24 papers)Lymphoma Diagnosis and Treatment (15 papers)
Cited by: Dermatology Immunology Chemical Health and Safety
Journals: Cell Proceedings of the National Academy of Sciences Journal of the American Chemical Society
Partner nations: Netherlands United States United Kingdom

In The Last Decade

Remco van Doorn

122 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network

2008 1.6k citations Remco van Doorn, Daniel S. Peeper et al. profile →

Peers

Countries citing papers authored by Remco van Doorn

Since Specialization

Citations

This map shows the geographic impact of Remco van Doorn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Remco van Doorn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Remco van Doorn more than expected).

Fields of papers citing papers by Remco van Doorn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Remco van Doorn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Remco van Doorn. The network helps show where Remco van Doorn may publish in the future.

Co-authorship network of co-authors of Remco van Doorn

This figure shows the co-authorship network connecting the top 25 collaborators of Remco van Doorn. A scholar is included among the top collaborators of Remco van Doorn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Remco van Doorn. Remco van Doorn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pyroglutamation of cell surface proteins CD47 and TRP1 by glutaminyl cyclase modulates therapeutic antibody binding 2025 ·Communications Biology ·(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Marjolein Sluijter,Tim van Groningen,Remco van Doorn,Thorbald van Hall,Roderick C. Slieker,Thomas H. Sharp,Joost B. Beltman,Kaspar Bresser,Ferenc A. Scheeren	0
2	Association Between Vascular NOTCH3 Aggregation and Disease Severity in a CADASIL Cohort – Implications for NOTCH3 Variant‐Specific Disease Prediction 2025 ·Annals of Neurology ·(unknown),Gido Gravesteijn,(unknown),(unknown),Mar Rodríguez‐Girondo,Benno Gesierich,Marie‐Noëlle W. Witjes‐Ané,Remco van Doorn,Marco Duering,Julie W. Rutten,Saskia A.J. Lesnik Oberstein	0
3	Reconsidering the surgical approach in cutaneous melanoma: does wide local excision after a complete diagnostic excision reduce the risk of recurrence? 2025 ·European Journal of Cancer ·(unknown),(unknown),Remco van Doorn,Annemiek Doeksen,Willeke A.M. Blokx,Yvonne Schrage,(unknown),Richard A. Scolyer,Emily L. Postma,(unknown)	1
4	Clinical outcomes and genomic profiles of MAP2K1-mutated primary cutaneous melanocytic tumours 2025 ·EBioMedicine ·(unknown),(unknown),(unknown),Frans Schutgens,(unknown),Anne‐Marie Cleton‐Jansen,Marijke R. van Dijk,Gerben E. Breimer,(unknown),Wendy W.J. de Leng,Remco van Doorn,Karijn P.M. Suijkerbuijk,Anne M.R. Schrader,Willeke A.M. Blokx	0
5	Melanoma arising from pre-existing naevus in carriers of a germline CDKN2A pathogenic variant 2024 ·British Journal of Dermatology ·(unknown),(unknown),Anne M.R. Schrader,Thomas P. Potjer,Ellen Kapiteijn,Jos A. van der Hage,Remco van Doorn	0
6	Mimicking fat grafting of fibrotic scars using 3D‐organotypic skin cultures 2023 ·Experimental Dermatology ·(unknown),(unknown),Marion Rietveld,(unknown),Roel E. Genders,Koen D. Quint,Remco van Doorn,Paul P. M. van Zuijlen,Abdoelwaheb El Ghalbzouri	3
7	A disease-associated XPA allele interferes with TFIIH binding and primarily affects transcription-coupled nucleotide excision repair 2023 ·Proceedings of the National Academy of Sciences ·Diana van den Heuvel,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Katja Apelt,Angela Kragten,Román González‐Prieto,Alfred C.O. Vertegaal,Jung-Eun Yeo,Byung‐Gyu Kim,Remco van Doorn,Orlando D. Schärer,Martijn S. Luijsterburg	13
8	NO TCH3 variant position is associated with NOTCH3 aggregation load in CADASIL vasculature 2021 ·Neuropathology and Applied Neurobiology ·Gido Gravesteijn,(unknown),Aat A. Mulder,(unknown),Remco van Doorn,Ingrid M. Hegeman,Carolina R. Jost,Julie W. Rutten,Saskia A.J. Lesnik Oberstein	26
9	Eight years of experience with vismodegib for advanced and multiple basal cell carcinoma patients in the Netherlands: a retrospective cohort study 2021 ·British Journal of Cancer ·(unknown),Marlies Wakkee,A.K.L. Reyners,Patty J. Nelemans,Maureen J.B. Aarts,Emöke Rácz,Jorrit B. Terra,Lot A. Devriese,(unknown),Ellen Kapiteijn,Remco van Doorn,Marcel W. Bekkenk,(unknown),Klara Mosterd	12
10	Genome‐wide characterization of 5‐hydoxymethylcytosine in melanoma reveals major differences with nevus 2020 ·Genes Chromosomes and Cancer ·Catarina Salgado,Jan Oosting,Bart Janssen,Rajiv Kumar,Nelleke A. Gruis,Remco van Doorn	8
11	Interplay between TERT promoter mutations and methylation culminates in chromatin accessibility and TERT expression 2020 ·PLoS ONE ·Catarina Salgado,(unknown),(unknown),Nelleke A. Gruis,Remco van Doorn,(unknown)	17
12	Association of HERV-K and LINE-1 Hypomethylation with Reduced Disease-Free Survival in Melanoma Patients 2020 ·Epigenomics ·Maurizio Cardelli,Remco van Doorn,(unknown),(unknown),Francesco Piacenza,Elisa Pierpaoli,Robertina Giacconi,Marco Malavolta,P. Sivaramakrishna Rachakonda,Nelleke A. Gruis,Anders Molven,Per Arne Andresen,Dace Pjanova,Joost J. van den Oord,Mauro Provinciali,Eduardo Nagore,Rajiv Kumar	13
13	Genome-wide analysis of constitutional DNA methylation in familial melanoma 2020 ·Clinical Epigenetics ·Catarina Salgado,Nelleke A. Gruis,Bastiaan T. Heijmans,Jan Oosting,Remco van Doorn	4
14	Families with BAP1-Tumor Predisposition Syndrome in The Netherlands: Path to Identification and a Proposal for Genetic Screening Guidelines 2019 ·Cancers ·Cindy Chau,Remco van Doorn,Natasha M. van Poppelen,Nienke van der Stoep,Arjen R. Mensenkamp,Rolf H. Sijmons,(unknown),Ans M.W. van den Ouweland,Nicole C. Naus,Annemieke H. van der Hout,Thomas P. Potjer,Fonnet E. Bleeker,Marijke R. Wevers,Liselotte P. van Hest,Marjolijn C.J. Jongmans,Marina Marinkovic,Jaco C. Bleeker,Martine J. Jager,Gregorius P. M. Luyten,Maartje Nielsen	39
15	Novel VECSEL for short‐wave infrared Raman spectroscopy applications 2017 ·Journal of Raman Spectroscopy ·Inês Santos,(unknown),Xi Gu,Peter J. Caspers,Tom C. Bakker Schut,Remco van Doorn,Vincent Noordhoek Hegt,Senada Koljenović,Gerwin J. Puppels	1
16	Genomic analysis and clinical management of adolescent cutaneous melanoma 2017 ·Pigment Cell & Melanoma Research ·Roy Rabbie,Mamunur Rashid,Ana Arance,Marcelo Sánchez,Gemma Tell‐Martí,Míriam Potrony,Carles Conill,Remco van Doorn,Stefan C. Dentro,Nelleke A. Gruis,Pippa Corrie,Vivek Iyer,Carla Daniela Robles‐Espinoza,Joan Anton Puig‐Butillé,Susana Puig,David J. Adams	10
17	Germline TERT promoter mutations are rare in familial melanoma 2015 ·Familial Cancer ·Mark Harland,Mia Petljak,Carla Daniela Robles‐Espinoza,Zhihao Ding,Nelleke A. Gruis,Remco van Doorn,Karen A. Pooley,Alison M. Dunning,Lauren G. Aoude,Karin Wadt,Anne‐Marie Gerdes,Kevin M. Brown,Nicholas K. Hayward,Julia Newton‐Bishop,David J. Adams,D. Timothy Bishop	43
18	Near‐genomewide RNA i screening for regulators of BRAF ^V ^600E ‐induced senescence identifies RASEF , a gene epigenetically silenced in melanoma 2014 ·Pigment Cell & Melanoma Research ·Joanna Kaplon,Hömig-Hölzel Cornelia,(unknown),Katrin Meissl,Els M.E. Verdegaal,Sjoerd H. van der Burg,Remco van Doorn,Daniel S. Peeper	13
19	Novel and Highly Recurrent Chromosomal Alterations in Sezary Syndrome 2008 ·Cancer Research ·Maarten H. Vermeer,Remco van Doorn,Remco Dijkman,Xin Mao,Sean Whittaker,Pieter C. van Voorst Vader,Marie‐Jeanne P. Gerritsen,Marie‐Louise Geerts,Sylke Gellrich,Ola Söderberg,Karl‐Johan Leuchowius,Ulf Landegren,Jacoba J. Out‐Luiting,Jeroen Knijnenburg,Marije IJszenga,Károly Szuhai,Rein Willemze,Cornelis P. Tensen	133
20	Aberrant DNA Methylation in Cutaneous Malignancies 2005 ·Seminars in Oncology ·Remco van Doorn,Nelleke A. Gruis,Rein Willemze,Pieter A. van der Velden,Cornelis P. Tensen	50

About Remco van Doorn

Remco van Doorn is a scholar working on Dermatology, Oncology and Cancer Research, having authored 128 papers that have together received 5.3k indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (26 papers), Cutaneous lymphoproliferative disorders research (24 papers) and Lymphoma Diagnosis and Treatment (15 papers). The work is most often cited by research in Dermatology (1.6k citations), Immunology (1.4k citations) and Chemical Health and Safety (42 citations). Remco van Doorn has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Rein Willemze, Daniel S. Peeper, Wolter J. Mooi, Chrysiis Michaloglou, Liesbeth C.W. Vredeveld, Sirith Douma, Christophe Desmet, Lucien A. Aarden, Thomas Kuilman and P.Th. Henderson. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact